Bupropion Hydrochloride
- Product NDC
- 50090-7109
- 11-digit product format
- 500907109
- Labeler code
- 50090
- Product ID
- 50090-7109_0ac2b05e-7638-4115-b98d-ec2d8307ba35
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA210081
- Marketing category
- ANDA
- Marketing start
- 2018-08-30
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| ZG7E5POY8O | BUPROPION HYDROCHLORIDE | 31677-93-7 | BUPROPION HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7109-0 | 50090710900 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50090-7109-0) | 2024-03-11 | No | No | Historical |